13 Kidney Cancer Clinical Trials in New York, NY (2026)

Q: How do I join a clinical trial in New York?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you.

Recruiting Kidney Cancer Studies in New York

NCT02087852Recruiting

Kidney Cancer DNA Registry

This registry will help us develop better methods of: * Preventing these cancers * Diagnosing these cancers * Treating these cancers...

New York, NY750 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07195682Recruiting

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

This is a first-in-human study of BMS-986506 in participants with advanced Clear Cell Renal Cell Carcinoma (ccRCC). The primary objective of this study is to find out if BMS-986506 is safe and can be ...

New York, NYPHASE1281 participantsBristol-Myers Squibb

View Study Details

NCT07646847Recruiting

A Study of a Side Effects and Resource Navigation Program for People With Cancer

The purpose of this study is to find out if the navigation program helps participants manage immunotherapy treatment better than usual care. Investigators will also look at how the navigation program ...

New York, NYNA200 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07049926Recruiting

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

Substudy 03C is part of a larger research study that is testing experimental treatments for renal cell carcinoma (RCC). The larger study is the umbrella study (U03). The goal of substudy 03C is to ev...

New York, NYPHASE1140 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06234605Recruiting

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

This is a Phase 1b, open-label, multicenter, safety, tolerability and efficacy study of HC-7366 in combination with belzutifan (WELIREG™). This is a multipart study that consists of a HC-7366 monother...

New York, NYPHASE180 participantsHiberCell, Inc.

View Study Details

NCT06863311Recruiting

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

The study population for this Phase 2 study will include men and women ≥ 18 with confirmed renal cell carcinoma who have progressed on adjuvant anti-PD-1/PD-L1 therapy, the current standard of care. S...

New York, NYPHASE270 participantsKarie Runcie

View Study Details

NCT04981509Recruiting

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

This phase II trial studies the effects of combination therapy with bevacizumab, erlotinib, and atezolizumab in treating patients with hereditary leiomyomatosis and kidney cancer that may have spread ...

New York, NYPHASE265 participantsNational Cancer Institute (NCI)

View Study Details

NCT06835972Recruiting

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

The researchers are doing this study to find out whether the combination of abemaciclib and cabozantinib is a safe and effective treatment for people with metastatic clear cell renal cell carcinoma (c...

New York, NYPHASE143 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05387863Recruiting

Decision Aid (DA) for Renal Patients

The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team...

New York, NYNA40 participantsNYU Langone Health

View Study Details

NCT07300241Recruiting

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

The NEO-811-101 study is an open-label, first-in-human, Phase 1/2 dose escalation and expansion study testing NEO-811, an ARNT molecular glue degrader, in subjects with locally advanced or metastatic ...

New York, NYPHASE130 participantsNeomorph, Inc

View Study Details

NCT07767500Recruiting

Stereotactic MR-Adaptive Radiation Therapy for Early-stage Renal Cancer

The purpose of this study is to investigate the use of an MR-guided linear accelerator to treat early stage renal cancer patients, considered inoperable or in patients declining surgerys. The study wi...

New York, NYNA30 participantsNYU Langone Health

View Study Details

NCT07179770Recruiting

Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC)

The purpose of this study is to identify changes in Carbonic Anhydrase IX (CAIX) expression induced by hypoxia-inducible factor 2 alpha (HIF-2α) inhibition by initiating belzutifan single agent therap...

New York, NYPHASE112 participantsNYU Langone Health

View Study Details

NCT06699602Recruiting

A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma

The researchers are doing this study to find out whether it is practical (feasible) to give cemiplimab and fianlimab before a nephrectomy and whether it causes any delays with surgery in people with k...

New York, NYPHASE210 participantsMemorial Sloan Kettering Cancer Center

View Study Details

About Kidney Cancer Clinical Trials in New York

Kidney cancer, most commonly renal cell carcinoma, develops in the lining of the kidney tubules. It accounts for about 3-5% of all adult cancers. Treatment includes surgery, targeted therapy, immunotherapy, and radiation.

There are currently 13 kidney cancer clinical trials recruiting participants in New York, NY. These studies are seeking a combined 1,751 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center, Bristol-Myers Squibb, Merck Sharp & Dohme LLC and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Kidney Cancer Clinical Trials in New York — FAQ

Are there kidney cancer clinical trials in New York?

Yes, there are 13 kidney cancer clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What kidney cancer treatments are being tested?

The 13 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for kidney cancer.

Data updated September 3, 2026 from ClinicalTrials.gov